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1996; Riggins et al., 1996). Both DPC4 (SMAD4) and
SMAD2 belong to the SMAD gene family involved in
the signal transduction pathways activated through the
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Although TGFb is one of the most potent inhibitors ofTsukuba 300-2611
normal cell growth, many malignancies of epithelial andJapan
hematopoietic origins are resistant to TGFb, suggesting²Laboratory of Biomedical Genetics
that developing resistance to TGFb plays an importantGraduate School of Pharmaceutical Sciences
role in tumorigenesis (Polyak, 1996). Tumors acquireThe University of Tokyo
resistance to TGFb relatively late during tumorigenesis,Tokyo 113-0033
and this usually correlates with developing invasivenessJapan
(Filmus and Kerbel, 1993; Fynan and Reiss, 1993). Tu-³Rowe Program in Genetics
mors can become resistant to TGFb in many differentDepartment of Biological Chemistry
ways (Polyak, 1996). Loss of both of the TGFb receptorsUniversity of California
(type I and type II) occurs infrequently in tumors butDavis, California 95616
has been observed in retinoblastomas and certain colon
carcinoma cell lines (Coffey et al., 1987; Kimchi et al.,
1988). Decreased expression of either type of receptorSummary
has been frequently observed in human tumor cell lines
(Filmus et al., 1992). TGFb type II receptor mutationsThe DPC4 (SMAD4) gene plays a key role in the TGFb
were found to be associated with microsatellite instabil-signaling pathway. We inactivated its mouse homolog
ity in colorectal carcinoma cell lines (Lu et al., 1995;Dpc4 (Smad4). The homozygous mutants were embry-
Markowitz et al., 1995). Resistance to TGFb can alsoonic lethal, whereas the heterozygotes showed no ab-
be caused by mutations that result in signaling defectsnormality. We then introduced the Dpc4 mutation into
(Filmus and Kerbel, 1993). While SMAD1 is a bone mor-the ApcD716 knockout mice, a model for human familial
phogenetic protein (BMP) signal transducer, SMAD2adenomatous polyposis. Because both Apc and Dpc4
and SMAD3 are TGFb/activin signal transducers. DPC4are located on chromosome 18, we constructed com-
(SMAD4), on the other hand,plays a pivotal role becausepound heterozygotes carrying both mutations on the
it is a shared and obligate partner of pathway-restrictedsame chromosome by meiotic recombination. In such
SMADs (Zhang et al.,1996; Lagna et al., 1996; Massaguemice, intestinal polyps developed into more malignant
et al., 1997). Both DPC4 (SMAD4) and SMAD2 are candi-tumors than those in the simple ApcD716 heterozygotes,
date tumor suppressor genes whose inactivation mayshowing an extensive stromal cell proliferation, sub-
play roles in pancreatic, colorectal, and possibly othermucosal invasion, cell type heterogeneity, and in vivo
human cancers (Eppert et al., 1996; Hahn et al., 1996;transplantability. These results indicate that mutations
Riggins et al., 1996). In addition to pancreatic carcino-in DPC4 (SMAD4) play a significant role in the malig-
mas, homozygous mutations of DPC4 (SMAD4) werenant progression of colorectal tumors.
found in up to 30% of colorectal cancers as well (Thia-
galingam et al., 1996; Moskaluk and Kern, 1996). How-
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ever, homozygous DPC4 (SMAD4) mutations appear to
be relatively uncommon (,10%) in other carcinomas
About 90% of human pancreatic carcinomas, and 30%± (Schutte et al., 1996).
65% of colorectal tumors have allelic loss at chromo-
To determine the role of the DPC4 mutation in carcino-
some 18q (Vogelstein et al., 1988; Hahn et al., 1996),
genesis, we constructed knockout mice in which its
where several candidates for tumor suppressor genes
homolog Dpc4 was inactivated by homologous recom-
were proposed (Kinzler and Vogelstein, 1996). Among bination. We then introduced the mutation into the
them, DCC has been demonstrated to be a receptor for ApcD716 knockout mice, a model for human familial ade-
the axonal chemoattractant netrin-1, rather than a tumor nomatous polyposis (FAP) (Oshima et al., 1995, 1997).
suppressor (Friess et al., 1993; Fazeli et al., 1997), leav- Because both Dpc4 and Apc are located on mouse chro-
ing DPC4 (SMAD4) and JV18±1 or MADR2 (SMAD2) as mosome 18 (Chr 18), we constructed compound hetero-
likely candidates. DPC4 (Deleted in pancreatic carci- zygotes by meiotic recombination in which both muta-
noma, or SMAD4, and formerly hMAD-4) was isolated tions were brought onto the same chromosome in the
from the convergent site of homozygous deletions on cis-configuration. In the tumors of these mice, both Apc
18q in a panel of pancreatic carcinomas (Hahn et al., and Dpc4 were homozygously inactivated by loss of
1996; Zhang et al., 1996). On theother hand, SMAD2 was heterozygosity (LOH). This LOH appears to be due to
isolated as a gene related to Drosophila Mad (Mothers the loss of the entire Chr 18 that contained the wild-
against Dpp) or human MADR1 (SMAD1) (Eppert et al., type alleles of Apc and Dpc4, followed by reduplication
of the remaining chromosome with the knockout alleles
for both genes. Accordingly, we have created viable§To whom correspondence should be addressed.
conditional mutant mice in which both Apc and Dpc4‖ Present address: Human Genetics, Merck Research Laboratories,
West Point, Pennsylvania 19486. are totally inactivated only in the tumor cells, despite
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Figure 1. Construction of Dpc4(1/2) Knock-
out Mice
(A) Strategy for targeting Dpc4 (Smad4). The
structures of the normal allele, targeting vec-
tor pDpc4, and targeted allele are shown.
Open boxes neo and DT-A indicate the neo-
mycin resistance gene and diphtheria toxin
a-subunit gene cassettes, respectively, de-
rived from plasmid pGK-neo-bpA (Soriano et
al., 1991). Exons are shown as filled boxes,
Ex1 (containing the translation initiation site,
ATG), Ex2, Ex3, and Ex4, whereas other geno-
mic segments are shown in solid lines. Only
relevant restriction sites are shown: A, ApaI;
H, HindIII, K, KpnI; S, SacI; St, StuI; and X,
XhoI.
(B) PCR data for homologous recombinant ES
cell clones. The positions of primers DPC4F1
and PGKR used for amplification are shown
as arrowheads in (A). The names of the re-
combinant ES cell clones are shown on top
of the lanes, whereas the position of the am-
plified fragment is shown on the right (1.2 kb;
arrow).
(C) Confirmation of homologous recombina-
tion in ES cell clones by Southern hybridiza-
tion. The positions of the hybridized HindIII
bands for the wild-type (8.5 kb; WT) and
knockout (6.8 kb; KO) alleles are shown, re-
spectively (arrows). The locations of the hy-
bridization probe (probe A) and the hybridiza-
ble HindIII fragments are shown in (A).
the fact that systemic homozygous inactivation of either genuine homologous recombinants (Figure 1C). Three
such clones were injected into C57BL/6 blastocysts,of these genes causes lethality in the early embryonic
life. and germline chimeras were generated. The Dpc4(1/2)
mice were viable and fertile, and appeared normal inAlthough it has been proposed to use unified nomen-
clature for the Smad gene family members (Derynck et their morphology and behavior. We have made exten-
sive histological examinations of the pancreas and theal., 1996), we have modified the symbols to meet the
standard formats for human and mouse gene symbols, intestines of these mice at various ages from 4 weeks
to 1 year. However, we could not find any noticeablerespectively. Namely, the human genes are shown in all
upper case, whereas the mouse genes are shown with difference from the wild-type littermates. This was the
case with the mice not only in the F1 (129/Sv 3 C57BL/intial capital only. While gene symbols are italicized,
upper case Roman letters are used to indicate the pro- 6) background, but also in their N5 (C57BL/6) backcross
generation.tein products of these genes. We have also used DPC4/
Dpc4 because of the historical reason and its prevalent When the progeny of the heterozygous intercrosses
was analyzed, no Dpc4(2/2) pups were found, with onlyuse in cancer research,with SMAD4/Smad4 inparenthe-
ses when appropriate. the wild-types and the heterozygotes at the ratio of 1:2,
indicating that the homozygous embryos died in utero
(data not shown). To determine the stage of lethality,Results
embryos were dissected at various ages of gestation,
and their genotypes were determined: Dpc4(2/2) em-Homozygous Inactivation of Dpc4 (Smad4)
bryos of the normal appearance were found only beforeCauses Early Embryonic Lethality,
7 dpc (data not shown). Homozygous mutants werewhereas Heterozygous Mutants
found at the Mendelian ratio when the preimplantationAppear Normal
embryos at 3.5 dpc were placed into culture and geno-A targeting vector was constructed (Figure 1A) in which
typed by PCR using the proliferated inner cell mass cellsexon 1 of Dpc4 (Smad4) was interrupted by a neomycin
(data not shown).resistance gene cassette (PGK-Neo-bpA) and was ex-
pected to truncate the peptide with 75 residues, accord-
ingly (Experimental Procedures). It was introduced by In Dpc4 and ApcD716 cis-Compound Heterozygote
Intestinal Tumors, Chromosome 18 Carrying theelectroporation into 129/Sv embryonic stem cell line
D3a2 (Shull et al., 1992). About 200 G418 resistant clones Wild-Type Alleles Is Lost whereas that Carrying
the Knockout Mutations Is Reduplicatedwere isolated, and seven homologous recombinant can-
didates were identified by a PCR screening (Figure 1B). Earlier, we constructed a mouse strain carrying knock-
out mutation ApcD716, which develops numerous polypsThey were all verified by Southern hybridization to be
Intestinal Carcinomas in Apc-Dpc4 Mutant Mice
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Figure 2. Strategy for Construction of ApcD716(1/2) Dpc4(1/2) Compound Heterozygotes
Only relevant alleles on Chr 18 are shown for simplicity.
(A) Dpc4(1/2) simple heterozygote.
(B) ApcD716(1/2) simple heterozygote.
(C) trans-compound heterozygote in the [Dpc4(1/2) 3 ApcD716(1/2)] F1. Note the two mutations on separate chromosomes.
(D) cis-compound heterozygote in the [Dpc4(1/2) 3 ApcD716(1/2)] F1 3 C57BL/6 backcross offsprings. Note the two mutations on the same
chromosome.
(E) Apc gene LOH caused by loss of the wild-type-carrying Chr 18, followed by reduplication of the mutation-carrying Chr 18 in the ApcD716(1/2)
simple heterozygote polyps.
(F) Apc gene LOH caused by loss of the wild type-carrying Chr 18, followed by reduplication of the mutation-carrying Chr 18 in the trans-
compound heterozygote. Note that the polyp genotype after the chromosomal loss and reduplication here should be the same as that in the
ApcD716 simple heterozygote in (E).
(G) LOH in both the Apc and Dpc genes by loss of the wild-type-carrying chromosome, followed by reduplication of the mutation-carrying
Chr 18 in the cis-compound heterozygote polyps. Experimental evidence has not yet been obtained for genotypes shown in parentheses.
in the intestines (Oshima et al., 1995, 1997)Ða mouse Dpc4 mapped on mouse Chr 18, about 30 centimorgans
(cM) distal to Apc. The linkage distances 6 SE betweenmodel for human FAP. While human APC is located on
5q21 (Groden et al., 1991; Kinzler et al., 1991), its mouse the markers were: Adrb2Ð5.3 6 2.1 cMÐD18Mit9Ð1.8 6
1.2 cMÐDpc4Ð2.6 6 1.5 cMÐD18Mit8. This result ishomolog Apc is on proximal Chr 18 (Luongo et al., 1993).
Although human DPC4 is on 18q21, its mouse homolog, consistent with the data of human and mouse homology
between these regions of the chromosomes (JohnsonDpc4, has recently been mapped to Chr 18 (Anna and
Devereux, 1997). We also mapped Dpc4 using a panel of and Davisson, 1997). It indicates the unique situation
that the two mouse genes Apc and Dpc4 are locatedinterspecific backcross mice and confirmed the results;
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Figure 3. PCR and FISH Analyses of the
Polyp Microadenoma Cells from the cis-Com-
pound Heterozygotes for the Apc and Dpc4
Loci
(A) Apc (top) and Dpc4 (bottom) gene LOH,
respectively, in dissected tumors determined
by PCR. The DNA extracted from normal in-
testinal epithelial samples from 4 mice (N1±
N4) and DNA from 12 polyp tumors from 3
mice (T1±T12) were genotyped using specific
primers for the wild-type and knockout al-
leles, respectively. The positions of the ampli-
fied bands for Apc and Dpc4 are shown on
the right, respectively (arrows; WT, wild-type
alleles; KO, knockout alleles). Lanes M were
loaded with molecular size markers.
(B) PCR genotyping of the cultured cells de-
rived from a tumor in a 14-week-old cis-com-
pound heterozygote. DNA was genotyped by
PCR for the Dpc4 gene to detect both the
wild-type and the knockout alleles. Note that
only the knockout Dpc4 allele was detected,
with the wild-type missing (lane T). Lane M
was loaded with size markers.
(C) FISH analysis for the Apc locus in the
interphase chromosomes of the cultured tu-
mor cells shown in (B) derived from the cis-
compound heterozygotes. Note that the rho-
damine-labeled probe was of a recombinant
phage P1 clone spanning about 100 kb of the
Apc locus. Accordingly, no difference in the
hybridization fluorescence is expected be-
tween the wild-type and knockout Apc al-
leles.
(D) DAPI-stained DNA fluorescence of the
same specimen as that in (C).
on the same chromosome, while their human homologs (T1±T12), whereas it remained in the normal intestinal
epithelium (N1±N4). We then determined the Dpc4 geno-are on separate chromosomes. Accordingly, we con-
structed compound heterozygotes in which the two mu- type in the same polyp microadenomas as those tested
for Apc. As shown in Figure 3A (bottom), the full-lengthtations were brought on the same Chr 18 in the cis-
configuration, and determined the effects of the Dpc4 wild-type Dpc4 band was also missing in the polyps
(T1±T12), although it remained in normal parts of theknockout mutation in the ApcD716 mutant mice. This strat-
egy is shown in Figure 2 together with the results of the intestinal epithelium (N1±N4)Ðindicating LOH for Dpc4
as well. These results strongly suggest that a wide rangechromosomal reduplication. First, the respective hetero-
zygotes (Figures 2A and 2B) were crossed, and F1 mice of Chr 18 that carried the wild-type alleles was missing
in the polyp microadenoma cells. To investigate the na-were obtained (Figure 2C). These compound heterozy-
gotes in the trans-configuration were then backcrossed ture of the Apc and Dpc4 LOH further, we placed some
polyp microadenomas from the cis-compound hetero-with the wild-type C57BL/6 mice. Their offspring con-
tained not only simple heterozygotes [55 ApcD716(1/2) zygotes into culture and obtained primary cells. We con-
firmed by PCR genotyping that these cultured cells wereand 41 Dpc4(1/2); i.e., 96 pups combined], but also
compound heterozygotes in the cis-configuration [Cis- of the tumor epithelial origin, but not of the stromal origin
because of their LOH in the Dpc4 gene (Figure 3B).ApcD716(1/2) Dpc4(1/2); 19 pups] (Figure 2D) and the
wild-type mice (23 pups) caused by meiotic recombina- Such interphase cells were analyzed by FISH using a
recombinant phage P1 probe which covered an z100tion. Because the Apc and Dpc4 genes are separated
by about 30 cM, this recombination frequency of 30.4% kb region in the Apc locus. As shown in Figure 3C, we
detected two hybridizing spots per cell, essentially in[(19 1 23)/(19 1 23 1 96)] precisely matches their linkage
distance. all cells. The same result was obtained with another
phage P1 probe for the Dpc4 locus (data not shown).As we demonstrated earlier (Oshima et al., 1995,
1997), LOH in the Apc gene is always associated with Another recombinant phage P1 probe for Chr 11 also
showed two spots, confirming the diploid nature of thethe formation of intestinal and colonic polyps in the
ApcD716 knockout mice, and it is likely to be the triggering cultured tumor cells (data not shown). These results,
taken together, strongly suggested that the whole Chrevent in tumorigenesis. This was confirmed for the polyp
microadenomas in the cis-compound heterozygotes as 18 carrying the wild-type Apc and Dpc4 alleles in the
cis-compound heterozygotes was lost, followed by re-well. As shown in Figure 3A (top), the PCR band for the
wild-type Apc allele was not detected in the polyps duplication of the Chr 18 with the knockout alleles. This
Intestinal Carcinomas in Apc-Dpc4 Mutant Mice
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In cis-Compound Heterozygotes, Polyps Develop
into Malignant Adenocarcinomas with Marked
Desmoplasia and Submucosal Invasion
In addition to the difference in the polyp number and
size, the morphology of the polyps was significantly
different in the cis-compound heterozygotes from that
of the ApcD716 heterozygotes. As we publishedpreviously
(Oshima et al., 1995, 1997), most intestinal polyps in the
ApcD716 heterozygotes were limited in the mucosal layer
(e.g., Figure 5A). On the other hand, the small intestinal
polyps in the cis-compound heterozygotes showed
more proliferation of the stromal (interstitial) cells than
in the ApcD716 heterozygotes, and discernible thickenings
of the smooth muscle layer were observed as early as
6 weeks of age (Figure 5B). To confirm the loss of theFigure 4. Polyp Size Distribution in the Small Intestine of the cis-
wild-type Dpc4 allele determined by PCR (Figure 3A), weCompound ApcD716 Dpc4 Heterozygotes Compared with that of the
stained the small intestinal polyps in the cis-compoundSimple ApcD716 Heterozygotes
heterozygotes with an antibody against the human(A) Polyp size distribution in the ApcD716 heterozygotes.
DPC4 protein. As shown in Figure 5C, the normal epithe-(B) Polyp size distribution in the cis-compound heterozygotes. The
bar patterns for the respective size classes are shown in the box lium of the villi as well as the crypts was stained. In
on the right (F, diameter in mm), whereas the ages are shown on contrast, the tumor epithelium of the polyps was not
the bottom. Mean values from 6 mice per group are shown as per- stained, while some staining was found in the stromal
centages for the respective size classes. (For the mice of 6 weeks, cells. When the nascent DNA was labeled with BrdU
sample number was 2 per group.)
and stained with its antibody, only crypts were stained
in the normal epithelium whereas the tumor cells were
stained all over the polyp (Figure 5D). Although the
process is shown schematically in Figure 2G. Accord- ApcD716 adenomas consisted of essentially enterocyte-
ingly, the polyp adenoma cells in the cis-compound het- like cells without mucinous differentiation (Figure 5E),
erozygotes resulted in conditional homozygous mutants the tumors in the cis-compound heterozygotes devel-
for both Apc and Dpc4 genes, with the rest of the genes oped into adenocarcinomas containing much more het-
on Chr 18 remaining unchanged from the background erogeneous types of cells, including mucinous cells, and
(see Discussion). showed marked submucosal invasions (Figure 5F). Such
mucinous cells were often found in more advanced in-
testinal tumors with extensive submucosal invasions,
In Dpc4 and ApcD716 cis-Compound Heterozygotes, showing theso-called ªsignet ring cellº appearance (Fig-
ures 5G and 5H) (Fenoglio-Preiser et al., 1990). The ma-Polyp Sizes Increase in the Small
lignant nature of these mucinous adenocarcinomas isand Large Intestines
also exemplified by a very high labeling index with BrdUAs shown in Figure 4, the polyps in the small intestine
(Figure 5I). In addition to the mucinous cells, some otherof the cis-compound heterozygotes were much larger
types of cells, such as dysplastic Paneth's cells werethan those in the ApcD716 heterozygotes at the age of 14
also observed (data not shown). Most cis-compoundweeks. The modal size was z1.0±2.0 mm in diameter
heterozygotes became moribund before 14±20 weeks,compared with ,0.5 mm in the ApcD716 heterozygotes.
and often (5/20) died of intussusception of the smallThis difference in the polyp size was not observed at 6
intestine, whereas such a complication was not foundweeks but became more apparent with age. Some co-
among 30 simple ApcD716 heterozygotes.lonic polyps in the cis-compound heterozygotes of both
The histopathological pictures were similar in the co-14 and 20 weeks developed to larger sizes that were
lonic tumors developed in the cis-compound heterozy-never found in the ApcD716 heterozygotes (e.g., F 5 7
gotes, except that a much more extensive proliferation
mm). This increase in the polyp size and the change in
of the stromal cells (desmoplasia) and an irregular archi-
the size distribution were confirmed with the cis-com-
tecture of the adenocarcinomas were observed. Figure
pound heterozygotes derived from Dpc4 heterozygotes
6 shows a comparison of age-matched colonic tumors
of further backcross generations as well (N5 in C57BL/6), between the ApcD716 mice and cis-compound heterozy-
but were not observed with the 20-week-old trans-com- gotes. While the ApcD716 polyps contained essentially
pound heterozygotes (data not shown). Regarding the homogeneous cells resembling colonocytes with sparse
polyp numbers, the cis-compound heterozygotes had stromal cells (Figures 6A and 6C), the cis-compound
much fewer polyps in the small intestine than the simple heterozygote polyps showed an extensive desmoplasia
ApcD716 heterozygotes. At 14 weeks, for example, the with a more irregular arrangement of the tumor glands
cis-compound heterozygotes had only 82 polyps, corre- (Figures 6B and 6D). Although not evident upon hema-
sponding to 12% of the 676 polyps in the ApcD716 hetero- toxylin and eosin (H & E) staining, the mucinous cells
zygotes. In contrast, the number of colonic polyps had were demonstrated in the cis-compound heterozygote
a tendency to increase in the cis-compound heterozy- polyps by Alcian blue staining (Figure 6F compared with
gotes at 14 and 20 weeks, although no colonic polyps 6E, respectively). In more advanced tumors in the cis-
compound heterozygotes, not only the cell type, butwere found at 6 weeks in either mutant (see Discussion).
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Figure 5. Histopathology of Small Intestinal
Polyps in the cis-Compound Heterozygotes,
Compared with Those in the Simple ApcD716
Heterozygotes
(A) An early polyp adenoma in a 6-week-old
ApcD716 heterozygote (control). Note that
no thickening of the smooth muscle layer is
observed underneath the polyp (arrows)
compared with the normal part (arrowhead).
(H & E.)
(B) An early polyp adenoma in a 6-week-old
cis-compound heterozygote. Note the thick-
ening of the smooth muscle layer and stromal
cell proliferation underneath the polyp (arrows)
compared with the normal part (arrowhead).
(H & E.)
(C) Immunohistochemical staining of a tumor
for the DPC4 protein in a 20-week-old cis-
compound heterozygote. A part of the tumor
is shown with the adjoining normal small in-
testinal tissue. (Hematoxylin counterstaining.)
(D) BrdU labeling of the nascent DNA stained
with a specific antibody in a tumor of a cis-
compound heterozygote. A section adjoin-
ing that used in (C). (Hematoxylin counter-
staining.)
(E) A polyp adenoma in a 20-week-old
ApcD716(1/2) mouse stained with Alcian blue
for sulfomucin-producing cells. Note that the
stained cells in the polyp are of the remaining
normal villus epithelium and crypts. (Hema-
toxylin counterstaining.)
(F) A polyp adenocarcinoma in a 20-week-
old cis-compound heterozygote stained with
Alcian blue. Note that many tumor cells are
stained not only in the mucosa, but also in the
muscle layer. (Hematoxylin counterstaining.)
(G) A more advanced tumor in a 20-week-old
cis-compound heterozygote with an exten-
sive submucosal invasion. (H & E.)
(H) A higher magnification of (G) showing ªsig-
net ring cells.º (H & E.)
(I) A section adjoining (H) stained for nascent
DNA by BrdU labeling.
Scale bars: (A)±(F), 250 mm; (G)±(I), 125 mm.
also the adenocarcinoma glands were heterogeneous. invasion at 14, 17, and 20 weeks of age. As shown
in Table 1, the invasive patterns in randomly sampledFor example, mucinous cell glands, colonocyte glands,
and glands with both types of cells were found in sin- tumors increased with age in the cis-compound hetero-
zygotes and reached more than half (55%) of the tumorsgle tumors (Figure 6G). Moreover, the submucosal inva-
sion was much more marked in the cis-compound at 20 weeks. In the ApcD716 polyps, on the other hand,
such invasive patterns were not found at all at 14 or 17tumors, often into the muscle layer (Figure 6H). Some
of these cells were examined further by electron micros- weeks of age, and only 2 were found out of 66 tumors
at 20 weeks. It is worth noting that these invasivecopy and their cell type identities were confirmed (data
not shown). The histology of the polyps in the trans- tumor cells incorporated BrdU extensively and were not
stained by an antibody against the human DPC4 proteincompound heterozygotes was not significantly different
from that in the simple ApcD716 heterozygotes (data not (data not shown).
We also collected some of these tumors at the ageshown).
To assess the invasiveness of the tumors in the cis- of 18 weeks, and transplanted them into nude mice
subcutaneously. Neither of the two ApcD716 polypscompound heterozygotes, we scored the submucosal
Intestinal Carcinomas in Apc-Dpc4 Mutant Mice
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Figure 6. Histopathology of Colonic Polyps
in the cis-Compound Heterozygotes, Com-
pared with Those in the ApcD716 Heterozy-
gotes
(A) One of the most representative tumors
developed in a 14-week-old ApcD716 simple
heterozygote. Inset: a higher magnification.
(H & E.)
(B) One of typical polyps in a 14-week-old cis-
compound heterozygote. Note that the polyp
contains much more stromal cells (areas with
less staining) compared with the tumor in (A).
Also note the difference in the size of the
polyps, based on the scale bar lengths. Inset:
a higher magnification. (H & E.)
(C) A highermagnification of an ApcD716 simple
heterozygote polyp (20-week-old). (H & E.)
(D) A higher magnification of a cis-compound
heterozygote polyp (20-week-old). Note ex-
tensive proliferation of the stromal cells
not tightly adhering to the tumor epithelium.
(H & E.)
(E) Alcian blue staining of the same tumor as
in (C).
(F) Alcian blue staining of the same tumor as
in (D). Note that some tumor cells are stained
for sulfomucin, a sign of mucinous adenocar-
cinoma.
(G) A tumor in a 14-week-old cis-compound
heterozygote. Note the tissue heterogeneity
of the adenocarcinoma glands consisting of
mucinous cells, and colonocytes, respec-
tively, as well as glands with both types of
cells.
(H) A tumor in a 14-week-old cis-compound
heterozygote. Note the pedunculate growth
of the submucosal layer with an extensive in-
vasion by the adenocarcinoma cells. (H & E.)
Scale bars: (A) and (B), 250 mm; (C)±(G), 125
mm; and (H), 250 mm.
formed tumors even after two months, whereas all three To determine other possible genetic changes associ-
ated with this malignant phenotype in the cis-compoundpolyps from the cis-compound heterozygotes devel-
heterozygotes, we placed the tumor cells into cultureoped into tumors. Histological examinations of these
and determined the DNA sequences for the K-ras genetumors showed a variety of adenocarcinomas including
(Kras2). Among 7 cell lines derived from 7 independentthe signet ring cell type (data not shown).
tumors, none of them showed mutations in the Kras2
hot spots corresponding to codon 12, 13, or 61 (dataTable 1. Submucosal Invasion of Intestinal Tumorsa
not shown).
Age (wk) Although examined extensively, no signs of metasta-
sis were found in the cis-compound heterozygotes byGenotype 14 17 20 Total
the time these mice became moribund at 14±20 weeks.Cis-ApcD716(1/2) Dpc4(1/2) 1/4 2/4 26/45 29/53
These results collectively indicate that inactivation ofApcD716(1/2) 0/11 0/12 2/43 2/66
the Dpc4 gene results in the malignant progression of
a Number of tumors with submucosal invasion / number of tumors the intestinal and colonic polyps initiated by LOH in the
examined.
Apc gene (see Discussion).
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Figure 7. Histopathology of a Duodenal Am-
pullary Tumor and of a Skin Epidermoid Cyst
in the cis-Compound Heterozygotes
(A±D) Histological sections of an ampullary
tumor in the duodenal papilla in a cis-com-
pound heterozygote. (A and C) Boxed area in
(A) is shown in (C) at a higher magnification.
(H & E.) (B and D) Immunohistochemical stain-
ing for the DPC4 protein. Boxed area in (B)
is shown in (D) at a higher magnification.
(Hematoxylin counterstaining.)
(E and F) Histological sections of a skin epi-
dermoid cyst in a cis-compound heterozy-
gote. (E) H & E staining. (F) Immunohisto-
chemical staining for the DPC4 protein. Note
that the tumor epidermal cells (arrow) are not
stained whereas the surrounding fibroblasts
(arrowhead) are stained by the antibody.
Scale bars: (A), (B), and (E), 250 mm; (C) and
(D), 62.5 mm; and (F), 10 mm.
Ampullary Tumors Develop in Duodenal Papilla and they were found in both male and female mice. A
representative histological picture is shown in Figure 7Eof Vater in cis-Compound Heterozygotes
Interestingly, 3 of the 15 cis-compound heterozygotes (see Discussion). No staining for the DPC4 protein was
found in the cysts (Figure 7F), suggesting a mechanismautopsied at 14±20 weeks had adenocarcinomas of sig-
nificant sizes in the ampullary region of the pancreatic to similar that causing intestinal tumors, i.e., LOH in both
Apc and Dpc4.duct in the major duodenal papilla (Figures 7A and 7C).
Their histology was similar to that of the tumors often
found in FAP patients (see Discussion). Immunohisto- Discussion
chemical staining of such tumors showed lack of the
Dpc4 protein (Figures 7B and 7D), suggesting the same We have inactivated the mouse Dpc4 (Smad4) gene by
homologous recombination in ES cells and establishedgenetic changes as in the intestinal tumors, i.e., the loss
of the Chr 18 that carried the wild-type alleles, followed germ-line transmitted mutant mice. Because Dpc4
(Smad4) is involved not only in the TGFb/activin path-by reduplication of Chr 18 that carried the knockout Apc
and Dpc4 alleles. On the other hand, none of the ApcD716 way, but also in the BMP-mediated pathway in early
embryogenesis (Massague et al., 1997), it is not surpris-mice had such tumors up to about 20 weeks of age,
though they were examined extensively. ing that the homozygous Dpc4 embryos are lethal
around 7 dpc, when BMP-2/4 plays critical roles in
mesoderm formation during gastrulation. It is worth not-Extra-GI Phenotypes in cis-Compound Heterozygotes
As the simple Dpc4 heterozygotes did not develop any ing that the homozygous knockout mutation in the type
I receptor gene for BMP (Bmpr) shows an embryonictumors in the pancreas, thorough histological examina-
tions of the pancreas of the cis-compound heterozy- lethal phenotype around 7 dpc (Mishina et al., 1995).
Taking advantage of the fact that Dpc4 and Apc aregotes did not reveal any malignant tumors at least up
to the age of 20 weeks, when most mice became mori- 30 cM apart on Chr 18, we then constructed by meiotic
recombination, compound heterozygotes that carriedbund due to the tumors of the intestines.
In 8 out of 15 (i.e., 53%) of the cis-compoundheterozy- the two knockout mutations on the same chromosome
(the cis-compound heterozygotes). In the tumor epithe-gotes older than 10 weeks of age, skin epidermoid cysts
were found in the left axillary region and/or the ventral lium developed in such mice, the wild-type allele of not
only Apc, but also Dpc4 was missing, suggesting lossside of the neck. The multiplicity of the macroscopically
visible cysts varied from one to two dozen per mouse, of the entire Chr 18. Because FISH analyses of the tumor
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cells showed two hybridizing spots per cell with either SMAD2 gene in sporadic colorectal carcinomas, two of
probe for the Apc or Dpc4 locus, reduplication of the which displayed LOH (Eppert et al., 1996).
mutant allele-carrying Chr 18 was strongly suggested. Although TGFb inhibits the growth of the normal cells,
Accordingly, both Apc and Dpc4 were totally inactivated many malignancies of epithelial and hematopoietic ori-
by the knockout mutations only in the tumor epithelium, gins are resistant to TGFb (Polyak, 1996). It can even
maintaining the diploid state for other genes. Thus, we stimulate the proliferation of some advanced stage tu-
excluded the possibility that the malignant tumor char- mors (Mulder et al., 1988; Jennings et al., 1991). We
acteristics in the cis-compound heterozygotes were have demonstrated that shutting off the TGFb signaling
synergistic effects of the Apc/Dpc4 inactivation and the pathway by the mutation of Dpc4 in the ApcD716 polyp
haploinsufficiency of other genes on Chr 18, which adenomas made their growth much more malignant in
would be expected if no reduplication occurred. This nature. While most of the data we have presented in this
reduplication is not the result of the malignant change report were collected from the mice of the F1 generation
in the cis-compound heterozygote tumors, because we regarding the Dpc4 mutation, essentially the same re-
found the same reduplication also in the adenoma cells sults have been obtained with the N4 (C57BL/6) back-
of the ApcD716 simple heterozygotes. cross generation as well, except for higher intestinal
Using F1 hybrid mice between the C57BL/6 and AKR polyp numbers. Moreover, ApcD716 heterozygous segreg-
or C3H genetic backgrounds, the polyp adenomas in ants from the cis-compound mutants of the F1 genera-
the Min mice and Apc1638N knockout mice were shown tion obtained by backcrosses with C57BL/6 mice, had
to have lost the entire Chr 18 that carried the wild-type similar numbers of polyps to the cis-compound parents;
allele (Luongo et al., 1994; Smits et al., 1997). In the Min much fewer than the ApcD716 heterozygotes of the N12
mice, however, a PCR determination suggested that backcross generation. However, the polyp size distribu-
the Chr 18 is not reduplicated, but remains monosomic tion and histopathology of the segregant ApcD716 and
(Luongo et al., 1994). Although the difference between the trans-compound heterozygotes were essentially the
their data and our results awaits further investigation, same as in the ApcD716 heterozygotes in the N12 genera-it is worth noting that reduplication of the remaining tion. Accordingly, the malignant phenotype we observed
chromosome is a commonly observed phenomenon in thecis-compound mutants was not due toother genes
(Cavenee and Hansen, 1986). in the genetic background, whereas the polyp number
We accelerated the LOH in both Dpc4 and Apc by a
was reduced by the background gene(s) brought in from
single event of Chr 18 loss, followed by reduplication.
the 129/Sv strain.
Accordingly, we demonstrated the malignant progres-
It is interesting that some of the cis-compound hetero-
sion of the intestinal tumors at a much earlier stage in
zygotes developed ampullary carcinomas in the duode-
the cis-compound heterozygotes than expected in the
nal papilla of Vater, while such tumors were not found
simple ApcD716 heterozygotes by natural accumulation
in the simple ApcD716 heterozygotes. In human FAP, theof such genetic changes. Recently, we reported that no
ampullary tumors are serious complications after thehot spot mutations were found in the K-ras gene in the
colectomy operations (Jagelman et al., 1988). DuodenalApcD716 polyp adenomas (Oshima et al., 1997). Likewise,
polyps occur in 45%±91% of FAP patients and are con-no K-, N- or H-ras, or p53 gene (Trp53) mutations were
sidered as premalignant lesions (Beckwith et al., 1991).found in the polyp adenomas of Apc1638N knockout mice
Most of them are clustered in the periampullary region,(Smits et al., 1997). In the present study, we found no
and they often become malignant (Sugihara et al., 1982;mutations in the K-ras gene hot spot at codon 12, 13,
Jagelman et al., 1988). In a large genetic study, Sana-or 61 in the malignant adenocarcinoma cells from the
bria et al. reported recently a statistically significantcis-compound mice, either. These results suggest that
familial segregation for the incidence and severity ofthe polyp adenomas initiated by Apc LOH can become
periampullary neoplasia. Although there was no correla-malignant with only additional inactivation of the Dpc4
tion between specific APC germline mutations and peri-gene. It is worth noting that Markowitz et al. reported
ampullary polyp frequency or severity, age was also athat a TGFb-resistant and malignant derivative of a be-
statistically significant variable. They predicted as-yet-nign cultured human colon adenoma cell line expressed
unidentified modifier genes or perhaps common envi-wild-type p53 (TP53) transcripts (Markowitz et al., 1994).
ronmental factors. However, the pedigree linkage of theMutations in genes such as ras and p53 may contribute
periampullary carcinomas was relatively weak, thoughto further changes such as metastatic characteristics.
statistically significant (Sanabria et al., 1996). Consider-We have not observed any metastatic foci in any organs
ing the fact that DPC4 (on 18q) and APC (on 5q) are onof the cis-compound heterozygotes, at least in their
different chromosomes in humans, it is possible thatshort life span of about 20 weeks.
some FAP kindreds already carry DPC4 mutations andConsidering the role of Dpc4 in the TGFb pathway
that DPC4 LOH is responsible for the malignant change(Massague et al., 1997), similar malignant phenotypes
of the ampullary adenomas. The age factor may alsocan be expected in the ApcD716 polyps by an additional
be explained by the time taken for the homozygoushomozygous inactivation in one of other genes in the
inactivation of DPC4, or one of the other genes in thepathway than Dpc4 as wellÐnamely, the gene for ligand
TGFb signaling pathway. On the other hand, in the cis-TGFb1, -b2, or -b3; TGFb receptor type I or II; or signal-
compound heterozygote mice, this takes place in a sin-ing proteins such as Smad2 or -3. Mouse Smad2 will be
gle event of Chr 18 loss followed by reduplication.particularly interesting in this regard because its human
We also observed that more than half of the cis-com-homolog is linked to DPC4 (SMAD4), only 4 cM proximal
pound heterozygotes developed epidermoid cysts ofon 18q21 (Eppert et al., 1996). In fact, Eppert et al. de-
scribed four inactivating missense mutations of the the skin. In Min mice, intraperitoneal injection of the
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Mapping of the Dpc4 (Smad4) on the Mouse Genomealkylating agent N-ethyl-N-nitrosourea (ENU) was re-
The informative RFLVs for Dpc4 were defined using TaqI; the C3Hported to increase the incidence of epidermoid cysts
allele showed a band of 7.4 kb, whereas that of M. spretus was 11.0up to about 60% (Shoemaker et al., 1995). It is conceiv-
kb. RFLVs and the segregation of Adrb2 have been described in
able that mutations introduced into the Dpc4 gene were Oakey et al., 1991, whereas D18Mit8 and D18Mit9 have been de-
responsible for the change. scribed in Gariboldi et al., 1995. The chromosomal locations of the
We did not observe any neoplasms in the pancreas genes were determined, using a panel of DNA samples from an
interspecific backcross between C3H/HeJ-gld and (C3H/HeJ-gld 3of the cis-compound heterozygote mice. Given the fact
M. spretus) F1 (Seldin et al., 1988). This panel has been characterizedthat DPC4 is homozygously inactivated in about a half
for over 1100 genetic markers throughout the genome.of pancreatic cancers (Hahn et al., 1996), the lack of
pancreatic cancers in the Apc/Dpc4 cis-compound het-
Polyp Scoring
erozygotes was somewhat surprising. This result may The number and size of the polyps were scored by a single examiner
be explained by two possibilities. First, LOH in Apc and (K. T.) as described (Oshima et al., 1995, 1996).
Dpc4 by loss and reduplication of Chr 18 may be a very
rare event in the mouse pancreas and does not take PCR Analysis for Apc and Dpc4 LOH
PCR primers and conditions for Apc LOH determination have beenplace before the cis-compound heterozygotes die of the
described previously (Oshima et al., 1995, 1997). Dpc4 LOH wasintestinal tumors. Second, in most pancreatic cancers,
determined using the following PCR primers; DPC4F1 describedthe triggering event may bemutation(s) in a gene(s)other
above and DE1R1 corresponding to the wild-type exon (59-TATGGT
than Apc. Although APC mutations are found in some GACACACTTGCTAGGATG-39). The knockout allele genotype was
pancreatic cancers, such mutations appear to be het- determined using the DPC4F1 and PGKR as described above.
erozygous (Horii et al., 1992). At the same time, DPC4
mutations are likely to affect the progression of the pan- Histopathological and Immunohistochemical Analyses
Tissue specimens were prepared according to the standard protocolcreatic tumors after the initiation process is triggered.
as described (Oshima et al., 1996, 1997). Polyclonal antibody againstThe high frequency of DPC4 mutation in pancreatic can-
human DPC4 protein was purchased from Santa Cruz Biotechnol-cers is consistent with their histological characteristics
ogy, CA. To determine the invasion score, polyps larger than 2 mmof marked desmoplasia (Kloppel, 1993), which we have
in diameter from 9 randomized mice were sectioned for each group,
demonstrated in the intestinal adenocarcinomas devel- stained with H & E, and scored. The BrdU labeling experiments were
oped in the Apc/Dpc4 cis-compound heterozygotes. performed according to the method described previously (Oshima
In conclusion, we have demonstrated that homozy- et al., 1997) using a kit from Boehringer Mannheim. Electron micro-
scopic samples were prepared, examined, and photographed bygous inactivation of the Dpc4 gene causes ApcD716 polyp
BML, Tokyo.adenomas to progress into malignant and invasive ade-
nocarcinomas without additional mutations.
FISH Analysis for Apc and Dpc4 Loci
in Interphase Tumor CellsExperimental Procedures
Interphase chromosomes were analyzed as described (Inazawa et
al., 1992).Dpc4 (Smad4) and ApcD716 Knockout Mice
Dpc4 (Smad4) knockout mice were constructed according to the
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